Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gauthier

Showing results (401-410 of 409) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 409 results.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometriumF Labrie, C Labrie, A Bélanger, et al.
The Journal of Prevention of Alzheimer'S Disease|November 30, 2017
EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention TrialsP Aisen, J Touchon, R Amariglio, et al.
The Journal of Prevention of Alzheimer'S Disease|December 20, 2017
EU./U.S. CTAD Task Force on Alzheimer's Trial PopulationsB Vellas, C Sampaio, R Bateman, et al.
Revue Neurologique|October 26, 2005
[Consensus statement on severe dementia]B Vellas, S Gauthier, H Allain, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2005
[Consensus statement on severe dementia]B Vellas, S Gauthier, H Allain, et al.
The Journal of Nutrition, Health & Aging|October 14, 2005
Consensus statement on dementia of Alzheimer type in the severe stageB Vellas, S Gauthier, H Allain, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical TrialsH Liu, J Li, E Ziegemeier, et al.
Neurology|October 21, 2005
Diagnosis and management of dementia with Lewy bodies: third report of the DLB ConsortiumI G McKeith, D W Dickson, J Lowe, et al.
Clinical Genetics|March 20, 2013
Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disabilityP Callier, B Aral, N Hanna, et al.
Pageof 41

Showing results (401-410 of 409) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 409 results.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometriumF Labrie, C Labrie, A Bélanger, et al.
The Journal of Prevention of Alzheimer'S Disease|November 30, 2017
EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention TrialsP Aisen, J Touchon, R Amariglio, et al.
The Journal of Prevention of Alzheimer'S Disease|December 20, 2017
EU./U.S. CTAD Task Force on Alzheimer's Trial PopulationsB Vellas, C Sampaio, R Bateman, et al.
Revue Neurologique|October 26, 2005
[Consensus statement on severe dementia]B Vellas, S Gauthier, H Allain, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2005
[Consensus statement on severe dementia]B Vellas, S Gauthier, H Allain, et al.
The Journal of Nutrition, Health & Aging|October 14, 2005
Consensus statement on dementia of Alzheimer type in the severe stageB Vellas, S Gauthier, H Allain, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical TrialsH Liu, J Li, E Ziegemeier, et al.
Neurology|October 21, 2005
Diagnosis and management of dementia with Lewy bodies: third report of the DLB ConsortiumI G McKeith, D W Dickson, J Lowe, et al.
Clinical Genetics|March 20, 2013
Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disabilityP Callier, B Aral, N Hanna, et al.
Pageof 41